This acquisition, representing 1.97% of their reported 13F AUM as of December 31, 2025, is not, in itself, remarkable. It is the act of allocation, the formal declaration of interest, that is… peculiar. A small stone dropped into a vast, indifferent ocean, yet the ripples, however faint, are undeniable. One suspects the ocean does not notice, but the stone, undoubtedly, feels the displacement.
SoundHound AI, a name that evokes images of spectral canines and the echoing void of the digital realm. It has suffered a decline, a fall from grace nearly seventy percent from its recent zenith. A most unfortunate circumstance, but not, perhaps, insurmountable. The company speaks of revenue doubling, a claim that would have once stirred the heart of any seasoned merchant, but now merely elicits a weary sigh. However, a margin expansion of eight hundred basis points – a figure so precise it feels like a bureaucratic invention – is not to be dismissed lightly. They dabble in voice technology, attempting to graft it onto a virtual agent, an endeavor reminiscent of attempting to teach a parrot to manage a bank. Yet, if they succeed in creating an agent that can understand the peculiar desires of customers – a task that often confounds even the most astute human – then a modest rise in the share price may be within reach. A pittance, perhaps, but a yield nonetheless.
So, I’ve been digging through the numbers, and there are a few players who consistently seem to…benefit from these little price surges. Not exactly a secret, but the details are…amusing. And by amusing, I mean infuriatingly predictable. Here’s the breakdown. Consider it a public service announcement, from one slightly cynical investor to another.
Now, predicting the demise of anything is a risky business. I once confidently predicted the Seattle Mariners would win the World Series. That didn’t end well. But with coal, the numbers are becoming rather insistent. It used to generate over half of America’s electricity. Today? Around 17%. Projections suggest that by 2035, it could be down to a mere 7%. That’s a significant drop, even for a seasoned pessimist like myself. And this isn’t some cyclical dip; it’s a fundamental shift in how we power things. A structural change, as the analysts like to say. Which translates, in plain English, to a very different investment landscape.
Recently, Meta has delivered a rather scrumptious bit of news to a little company called Nebius Group (NBIS +2.56%). A deal, you see, a proper, whopping, five-year deal.
The company continues to report growth in revenue and profit, which, in the current climate, is itself a noteworthy achievement. However, the figures obscure a fundamental shift in the cost structure, a consequence of the escalating competition in the field of artificial intelligence. The pursuit of AI dominance is proving to be a costly endeavor, and the market appears to be belatedly recognizing this.
Now, investors, ever the eager audience, turn their gaze upon Lockheed Martin [LMT 0.89%], wondering if this Hellenic largesse shall bestow upon the company a further ascent. A perfectly reasonable inquiry, one might say, were it not for the inconvenient truth that markets, like fickle patrons, are rarely swayed by logic alone. Over the past week, a period coinciding with these pronouncements from Athens, Lockheed’s shares experienced a slight… repose. A dip of 2.52%, to be precise. A modest setback, perhaps, but a reminder that even the most impressive fortifications require constant vigilance.
As of the last count, December 31st, that stake now represents 9.19% of Land & Buildings’ holdings, a significant weight in a portfolio built on the assessment of value. They hold other properties, of course – FR, AHR, EQIX, VTR, and NSA – each a piece of the puzzle, but it’s Centerspace, with its focus on the Midwest and Mountain West, that seems to be holding their attention. A quiet attention, mind you, not the shout of speculation, but the steady gaze of a farmer assessing his fields.
Look, the man sold 3.41% of his holdings. 3.41%! It’s practically a rounding error. He’s trimming the fat, folks. Like a skilled butcher, not a panicked chef. And yes, the shares were sold to cover taxes. Imagine, a CEO paying taxes! The scandal!
Pfizer, now he’s a hefty fellow. A proper bruiser of a company, with fingers in more pies than you can shake a stick at. A market cap of 156 billion! Goodness gracious. They make all sorts of things, not just sneeze-preventers. They’re like a grand old apothecary, stocked to the rafters with remedies. Even with the cough-potion sales slowing, they still haul in over 60 billion a year. They have a pipeline of new brews bubbling away, though they’re facing a bit of a pickle with some patents expiring. But a giant like Pfizer can usually cushion the blow. They don’t wobble easily, you understand. They’re rather… substantial.